Medical Weight Loss for Gary, Indiana Residents
Gary, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Gary through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Gary Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Gary, Indiana residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Gary is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Gary address.
In Gary, Indiana, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout downtown Gary and the Northwest Indiana area of Lake County near Chicago. Whether you are starting your first GLP-1 program or switching from a brand medication, your Gary treatment plan is built around your health history and goals.
For Gary residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Gary is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month · just $7.70/day for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Gary
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Gary
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Gary address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Gary
Does New Hope Weight Loss treat patients in Gary?
Yes. Although the clinic is in Costa Mesa, California, we treat Gary, Indiana residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Gary?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Gary address in cold-pack packaging.
What do Gary patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Gary do you serve?
We serve patients from across Gary by telehealth, including downtown Gary and the Northwest Indiana area of Lake County near Chicago.
What makes this different from a local Gary medspa or clinic?
A named, licensed physician, Dr. Anjmun Sharma, supervises every case. Contraindications are screened at intake, the 503(a) compounding pharmacy is identified, and pricing is flat and stated up front. Gary patients get a real physician-led medical practice by telehealth, not a quick membership sign-up.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Gary, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.